搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
on MSN
3 side effects from colorectal cancer people don’t talk about, including a ‘source of ...
When we think of cancer, we often focus on the big symptoms, but colorectal cancer comes with side effects that don’t always ...
NL Times
1 天
New cancer treatment delivers direct chemotherapy to the liver
A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...
2 天
on MSN
Woman shocked 5 colon cancer symptoms she dismissed led to diagnosis at 30
She blamed irritable bowel syndrome, constipation and even a tight bra. Looking back, she had some classic symptoms of colon ...
3 天
on MSN
Woman denied stage 4 colon cancer treatment finds ally in her HR department
NBC 5 Responds is taking a deep dive into health insurance denials and the creative solutions many are using to get their ...
Daily
3 天
Blood test could guide use of celecoxib to reduce risk of colon cancer recurrence: Study
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
1 天
Artemisia herba-alba: Scientists Have Discovered That a Common Herb Could Help Treat Colon ...
Researchers have found that Artemisia herba-alba, a medicinal herb, contains compounds capable of fighting colorectal cancer.
5 天
Pfizer Trial For Colorectal Cancer Treatment Shows Improved Survival In Late-Stage Study
Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...
ascopubs.org
12 天
Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon ...
Avutometinib plus cetuximab after chemotherapy in patients with KRAS-mutated metastatic colorectal cancer: Results of phase 1 dose escalation. Immune checkpoint inhibitors in digestive tumors with ...
healthday on MSN
4 天
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard ch ...
Cure Today
5 天
Breaking Down Cancer Therapies Approved by the FDA in January 2025
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
earth
11 天
Medicinal plant has great potential to fight colorectal cancer
Artemisia herba-alba shows promise in combating colorectal cancer, offering new hope through its powerful medicinal ...
Cure Today
13 天
The BREAKWATER Trial Explores Braftovi, Erbitux and Chemo in BRAF V600E+ mCRC
Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈